Trial Profile
COVID Vaccine VAC31518 Pre-approval Access Study
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 01 Apr 2021
Price :
$35
*
At a glance
- Drugs Ad26.COV2 S (Primary)
- Indications COVID 2019 infections
- Focus Expanded access; Therapeutic Use
- Sponsors Janssen Research & Development
- 01 Apr 2021 New trial record